Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (DRKS00040834) titled 'RISE-VR Treat' on Sept. 3.
Study Type: interventional
Study Design:
Allocation: Randomized controlled study
Masking: Blinded (masking used)
Control: active
Assignment: parallel
Study design purpose: treatment
Primary Sponsor: Professur fur Klinische Psychologie und Psychotherapie des Kindes- und Jugendalters
Condition:
F32
F41
F33
Depressive episode
Other anxiety disorders
Recurrent depressive disorder
Intervention:
Group 1: Virtual Reality Application RISE-VR and Psychotherapy.
Group 2: Psychotherapy....
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 15/09/2026
Target Sampl...